The catch is that lower dose is not automatically same result at less risk. A dose that is too low for your biology may simply underperform while still carrying side effects
Some stay at this dose indefinitely, while others continue to the maximum
STEP-1: Semaglutide 2.4 mg In STEP-1 (N=1,961), adults with BMI 30 (or 27 with at least one weight-related comorbidity) received semaglutide 2.4 mg weekly or placebo for 68 weeks
The melanin already synthesised will fade on its natural 34 week timeline as keratinocytes turn over
Multiple customer reviews describe difficulty reaching support staff when issues arise, particularly around shipping delays and medication concerns
Regional defects, such as blunted antral contractions, spastic pyloric and small intestinal motility, hypersensitivity to fundic distention and impaired gastric accommodation to meals are demonstrable in diabetic patients